Abstract
Background: Gastroenteropancreatic neuroendocrine tumors (GEP NETs) are most often diagnosed at an advanced stage with synchronous hepatic metastasis. Surgical management strategies for these patients are controversial, with Level I evidence lacking given the rarity of this diagnosis. We therefore used a national database to investigate survival outcomes associated with resection of primary tumor, resection of the liver metastases, or resection of both the primary tumor and liver metastases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
